public service for those who think the supply of 37 cent shares will dry up soon
This morning, Cytomedix, Inc. (CMXI) announced it had secured $27.5 million in long-term financing through a mixed offering of debt and equity. Included in the transaction is a tranched $7.5 million senior secured term loan facility, a $5 million equity raise, and a $15 million committed equity financing facility. We believe the addition of these funds will allow the company to execute on its 2013 operational business plan, which includes moving forward with the AutoloGel registry program designed to provide evidence for the National Coverage Determination issued by the Center for Medicare and Medicaid Services (CMS) last August 2012, and continuing to enroll patients in the company's ongoing phase 2 RECOVER-Stroke program with ALD-401.
and in 2010
GAITHERSBURG, Md., Oct. 8, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
The Company has entered into a securities purchase agreement with certain existing shareholders and a new institutional investor for the sale of 3,727,677 shares of its common stock in a registered direct offering priced at $0.40 per share for non-affiliates and $0.53 for affiliates. In addition, warrants to purchase an aggregate of 1,863,839 shares of common stock will be issued to the investors. The warrants are exercisable beginning April 6, 2011, expire five years after initially exercisable and have an exercise price of $0.60 per share. Lincoln Park Capital Fund, LLC ("LPC" or "Lincoln Park") led the transaction with a $500,000 investment in this registered direct offering.
And to purchase Aldagen with lots of cmxi stock
Under the terms of the agreement, Cytomedix issued Aldagen shareholders preferred shares valued
It certainly is getting harder to get shares at 35 cents. Sellers seem stubborn for 36 cents. Some good news and they will want 37 cents.
The great thing is that every day is a little better bargain and more reason to keep accumulating. Every penny down buy twice as many shares as the day before. At 29 cents, how many shares will you be buying. kinda fun.
Not ONE large seller but sins of past financing have resulted in people who do not want to be invested with Martin any longer. Past financing to help buy that other company that Martin failed. Lot of shares out there and if Martin gets his way, there will many many more to help finance his lifestyle.
how many times will they launch this effort? Got so old, they changed names to make it look like a fresh start
A case study highlighting the unique healing ability of Aurix titled "Platelet Rich Plasma Gel Consistently Reduces Pressure Ulcer Size" (Poster #CS-020) has been accepted for poster presentation and will be discussed by lead author Carelyn P. Fylling, R.N., M.S.N., C.W.S, C.L.N.C., Vice President, Professional Services on Friday, October 17 starting at 8:00 a.m. PT. The findings, which demonstrated that Aurix reduced pressure ulcer area by 46-50% and volume by 60-67% in just 3.5 weeks, were released and presented during an oral presentation at the SAWC Spring 2014 meeting earlier this year.
Big launch last night at the ferris wheel and at this morning presentation. Surprised the price is falling with all this exciting news.
You know I was really peeved about Martin giving himself huge raise and bonus for getting almost CMS approval. Yes he did his job but the share price was hitting 52 week lows while he was rewarding himself. To me, that showed no skin in the game with shareholders. I worry that Tozer will be tempted by the same greed that turned Martin. While we hit larger and larger sales numbers, our costs continue upward because of salaries and other expenses. They can give themselves huge bonuses, options, pay raises because of the sales numbers but shareprice struggles due to dilution and lower than expected profits.
I think Tozer will deliver a huge ramp in sales. I think he will get rich along with Martin. The company has the best in class technology for wound care. I have not seen CMXI management care about shareholder value. Because they don't care about shareholders, I think despite what I think Tozer does, shareholders will see meager improvement on investment. Better plays out there than with Martin. And I think Jason knows that and should be warning new investors of the management.
$CMXI changing names to Nuo Therapeutics http://finance.yahoo.com/news/cytomedix-brands-nuo-therapeutics-123000898.html … // Up next, a 1-for-10 reverse stock split and uplist to the NASDAQ
He does not discuss the where the stock price will go after the 1-10 reverse .... say it goes to 3.79 after the split. How many really believe it will hold or increase from there? Bet most of you realize with Martin, the price will got back to $2. Then next year, he will issue more shares to fund "sales expansion". That would make the equivalent of being at 12 cents.
Like I have said, Martin and his band of yes men on the board are no friends to shareholders. At least not in my opinion from what I have seen.
This company has repeatedly shown they do not care about shareholder value. Their disdain for shareholders makes me wonder how Jason can pump them. WHat does he get?
and if they don't do anything, go to SEC. Persistence against evil.
does anyone consider it milking or bleeding the shareholders with their antics? bonuses up the yazoo without any performance causing massive dilution for shareholders to suck up. I hate their smugness as they get rich from shareholders.
things to consider. evaluate management's performance or lack there of compared to how they reward themselves.
another type gives themselves bonuses win or lose. They don't really care if shareholders gain anything, they are in it for themselves. Get a big group of like minded selfish no integrity folks all on the board together, laughing and joking about their money making venture. Hype it up to the shareholders so they buy everytime it's time to dilute. If CMXI was the real deal, insiders would be buying a whole lot more.
Many chiefs (or hogs) first in line to be fed. They want their bonuses and options. Even the CFO who got fired got himself a nice bonus. Shareholders getting milked bigtime. Notice when this gets put in print the sunshine pumpers come out enmasse. Overwhelming bs to distract you from seeing management's hands in the cookie jar. Doubt if anything will be left for shareholders. these guys are slick. Look how many there are.
They are too smart to go to jail. Not shareholder friendly but getting rich nonetheless. milking shareholders. laughing all the way to the private club.
Sounds great unless Martin plans include later in the year following the reverse with dilution .... he is very comfortable selling shares to finance his bonuses and pay check. Better than bankruptcy but not very shareholder friendly. After recent lawyer investigation pertaining to failure to fulfill fiduciary responsibility towards shareholders, the boys at CMXI are more careful to stay within the law. Does not mean ethical or integrity .... just within the law. Anyone really think Tozer cares to help shareholder?